[COX-2 inhibitors and cardiovascular adverse effects].
Harg
P
P
pernille.harg@legemiddelverket.no
Madsen
S
S
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D000075202:Contraindications; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D012307:Risk Factors
D016861:Cyclooxygenase Inhibitors; D010975:Platelet Aggregation Inhibitors